AIP
MRVI icon

Ameritas Investment Partners’s Maravai LifeSciences MRVI Stock Holding History

Ameritas Investment Partners’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.6K Hold
10,821
– – ﹤0.01% 2372
2025
Q4 		$35.2K Hold
10,821
– – ﹤0.01% 2355
2025
Q3 		$31.1K Hold
10,821
– – ﹤0.01% 2464
2025
Q2 		$26.1K Hold
10,821
– – ﹤0.01% 2542
2025
Q1 		$23.9K Hold
10,821
– – ﹤0.01% 2478
2024
Q4 		$59K Hold
10,821
– – ﹤0.01% 2088
2024
Q3 		$89.9K Hold
10,821
– – ﹤0.01% 1867
2024
Q2 		$77.5K Buy
+10,821
New +$93.4K ﹤0.01% 1890

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's MRVI Position: Q1 2026 in Review

Ameritas Investment Partners held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 10,821 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Ameritas Investment Partners first reported a position in MRVI in Q2 2024 and has held it in 8 quarters since. The position peaked at $89.9K in Q3 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Ameritas Investment Partners held 10,821 shares of Maravai LifeSciences worth $30.6K as of Q1 2026.
  • Ameritas Investment Partners left its Maravai LifeSciences share count unchanged in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2372 holding.
  • Ameritas Investment Partners first reported a position in Maravai LifeSciences in Q2 2024 and has held it in 8 quarters since.
  • Ameritas Investment Partners's Maravai LifeSciences position peaked at $89.9K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.